Our study is the first showing a relationship between NKA activation, GSK3β activation, reduction of EB1 comet length at MT plus-end, and inhibition of GBM cell migration at sub-cytotoxic concentrations of ProA. This evidence concerns the gene GSK3B and glioblastoma.